TTrialPathMatch Me to Trials
← Back to trials
RecruitingTransient Global Amnesia

PRevalence Of Transient Global Amnesia in Obstructive Sleep Apnea Syndrome

Eligible age

18+ yrs

Accepts

All genders

Locations

0 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Amnesic stroke is an amnestic syndrome lasting less than 24 hours characterized by the occurrence of anterograde amnesia often associated with retrograde amnesia, the pathophysiology of which is still poorly understood at present. A recent study on a small sample size (N=29) highlighted an association between obstructive sleep apnea syndrome and amnesic stroke. Our study seeks to confirm or refute these results on a larger cohort (N=200-250). A better understanding of the pathophysiological processes involved would open up new therapeutic avenues.

Sponsor: University Hospital, Strasbourg, France

You may qualify if…

  • ✓ Adult patients seen for consultation in the Neuropsychology Department of Strasbourg University Hospital between March 1, 2015 and December 31, 2021 following an episode of amnestic stroke meeting the Hodges and Warlow criteria:
  • ✓ The stroke must have been documented and reported by a competent witness present during the stroke.
  • ✓ Anterograde amnesia during the stroke.
  • ✓ Absence of vigilance, personality, and cognitive disorders other than memory disorders (aphasia, apraxia, etc.).
  • ✓ Absence of focal neurological symptoms during the episode and its aftermath.
  • ✓ Absence of epileptic manifestations.
  • ✓ Resolution of the episode in less than 24 hours.
  • ✓ Exclusion of patients with a history of recent head trauma or active epilepsy (undergoing regular treatment or having experienced a seizure in the last 2 years).

You may not qualify if…

  • ✕ Patients who have expressed opposition to the retrospective reuse of their data for scientific research purposes.
  • ✕ Patients with active epilepsy
  • ✕ Patients with recent head trauma
  • ✕ Patients with an MMS \< or equal to 25
  • ✕ Subject under guardianship or curatorship
  • ✕ Subject under judicial protection

Source: ClinicalTrials.gov · NCT06903026 · last updated 2025-03-30